Bryce Point Capital, LLC
- SEC CIK
- 0002019492
- Latest filing
- Nov 6, 2025
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Bryce Point Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q3 2025 holdings
- Shares (Q3 2025)
- 4,254
- Value
- $597.2K
- % of portfolio
- 0.7%
- Quarters held
- 2
- Since Q1 2025